DEVELOPMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the field of biopharmaceuticals, supplying promising progress throughout a variety of medical and industrial applications. With its structural similarity to Normally derived human serum albumin, OsrHSA gives a safer, far more reputable substitute for therapeutic use